In attempting to seek possible explanations of significant heterogeneity, stratifying studies that assessed circulating apelin concentration between CAD patients and controls by continent, endpoint, apelin source, matching status, sample size, obesity and hypertension were conducted, respectively (Table 4). This evidence concerns the gene APLN and coronary artery disorder.